- Home
- SWTX vs ERO Comparison
SWTX vs ERO Comparison
Compare SWTX & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWTX
- ERO
- Stock Information
- Founded
- SWTX 2017
- ERO 2016
- Country
- SWTX United States
- ERO Canada
- Employees
- SWTX N/A
- ERO N/A
- Industry
- SWTX Biotechnology: Pharmaceutical Preparations
- ERO
- Sector
- SWTX Health Care
- ERO
- Exchange
- SWTX Nasdaq
- ERO Nasdaq
- Market Cap
- SWTX 2.2B
- ERO 1.9B
- IPO Year
- SWTX 2019
- ERO N/A
- Fundamental
- Price
- SWTX $37.59
- ERO $13.29
- Analyst Decision
- SWTX Strong Buy
- ERO Strong Buy
- Analyst Count
- SWTX 5
- ERO 1
- Target Price
- SWTX $67.00
- ERO $19.00
- AVG Volume (30 Days)
- SWTX 1.1M
- ERO 383.7K
- Earning Date
- SWTX 11-12-2024
- ERO 11-05-2024
- Dividend Yield
- SWTX N/A
- ERO N/A
- EPS Growth
- SWTX N/A
- ERO N/A
- EPS
- SWTX N/A
- ERO 0.17
- Revenue
- SWTX $135,487,000.00
- ERO $464,134,000.00
- Revenue This Year
- SWTX $3,426.90
- ERO $27.14
- Revenue Next Year
- SWTX $88.92
- ERO $88.97
- P/E Ratio
- SWTX N/A
- ERO $79.62
- Revenue Growth
- SWTX N/A
- ERO 8.51
- 52 Week Low
- SWTX $28.21
- ERO $13.07
- 52 Week High
- SWTX $53.92
- ERO $24.34
- Technical
- Relative Strength Index (RSI)
- SWTX 46.01
- ERO 27.85
- Support Level
- SWTX $37.26
- ERO $13.07
- Resistance Level
- SWTX $42.51
- ERO $15.34
- Average True Range (ATR)
- SWTX 1.60
- ERO 0.48
- MACD
- SWTX -0.75
- ERO -0.02
- Stochastic Oscillator
- SWTX 4.37
- ERO 7.90
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.